Sotera Health Company
SHCHealthcareNASDAQDiagnostics & Research · Last scanned Oct 26, 2026
Scan Results
Daily timeframeSotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. Valued at $5.17B, SHC is a mid-cap name in its sector. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Market Cap
$5.17B
Beta
1.85
P/E (TTM)
31.75
P/E (Fwd)
16.84
EPS (TTM)
$0.57
EPS (Fwd)
$1.07
ROE
27.8%
ROA
8.6%
Cash
$357.0M
Total Debt
$2.27B
Free CF
$154.0M
52W Change
8.3%
Annual Financials
Cash vs Debt
Where SHC stands vs its 150-day and 200-day moving averages
As of the September 14, 2026 close, SHC finished 11.00% above its 150-day moving average ($16.55) and 8.89% above its 200-day moving average ($16.87). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SHC overbought or oversold?
At the September 14, 2026 close, SHC's RSI(14) was 29.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Sotera Health Company carries $2.27B in total debt against $357.0M in cash reserves — debt is roughly 6.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $154.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 27.8% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.6% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $1.00B to $1.16B.
With a beta above 1.5, SHC tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Sotera Health Company and its sector.